MT Newswires
RBC Raises Price Target on Fulcrum Therapeutics to $10 From $7, Keeps Sector Perform, Speculative Risk
📊
AI Sentiment
Positive
6/10
Latest updates and market news for FULC
AI Sentiment
Positive
6/10
AI Sentiment
Positive
7/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Positive
6/10
Share this news page